Aerosolized, Gas-Phase, Intravitreal Methotrexate Reduces Proliferative Vitreoretinopathy in a Randomized Trial in a Porcine Model
暂无分享,去创建一个
[1] H. Tayyab,et al. Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study , 2021, Cureus.
[2] M. Leila,et al. Anatomical and Functional Outcomes of Vitrectomy with/without Intravitreal Methotrexate Infusion for Management of Proliferative Vitreoretinopathy Secondary to Rhegmatogenous Retinal Detachment , 2021, Journal of ophthalmology.
[3] Lihteh Wu,et al. Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.
[4] D. Eliott,et al. Molecular Targets for Proliferative Vitreoretinopathy , 2021, Seminars in ophthalmology.
[5] E. Weichel,et al. Proliferative Vitreoretinopathy After Combat Ocular Trauma in Operation Iraqi Freedom and Operation Enduring Freedom: 2001-2011. , 2020, Ophthalmic surgery, lasers & imaging retina.
[6] K. Falavarjani,et al. Intra-silicone Oil Injection of Methotrexate in Retinal Reattachment Surgery for Proliferative Vitreoretinopathy , 2020, Ocular immunology and inflammation.
[7] T. Sheidow,et al. Acupuncture resulting in eye penetration and proliferative vitreoretinopathy – Surgical and medical management with intraocular methotrexate , 2020, American journal of ophthalmology case reports.
[8] H. Mudhar. A brief review of the histopathology of proliferative vitreoretinopathy (PVR) , 2019, Eye.
[9] H. Ahmadieh,et al. Repeated Injection of Methotrexate into Silicone Oil-Filled Eyes for Grade C Proliferative Vitreoretinopathy: A Pilot Study , 2019, Ophthalmologica.
[10] J. D. Benner,et al. Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy , 2019, BMJ Open Ophthalmology.
[11] Jiong Yan,et al. Formulation of a Peribulbar Block for Prolonged Postoperative Pain Management in Vitreoretinal Surgery: A Randomized Clinical Trial. , 2017, Ophthalmology. Retina.
[12] D. Eliott,et al. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy , 2017, Investigative ophthalmology & visual science.
[13] M. Duncan,et al. Intravitreal methotrexate infusion for proliferative vitreoretinopathy , 2016, Clinical ophthalmology.
[14] K. Falavarjani,et al. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy , 2015, Eye.
[15] H. Kaplan,et al. Proliferative vitreoretinopathy in the Swine-a new model. , 2012, Investigative ophthalmology & visual science.
[16] J. Pulido,et al. THE SAFETY OF INTRAOCULAR METHOTREXATE IN SILICONE-FILLED EYES , 2008, Retina.
[17] T. Olsen,et al. Intraocular nanoparticle drug delivery: a pilot study using an aerosol during pars plana vitrectomy. , 2007, Investigative ophthalmology & visual science.
[18] J. Pulido,et al. Intraocular methotrexate in ocular diseases other than primary central nervous system lymphoma. , 2006, American journal of ophthalmology.
[19] W. Hubbard,et al. Porcine sclera: thickness and surface area. , 2002, Investigative ophthalmology & visual science.
[20] P. Girard,et al. CLINICAL RISK FACTORS FOR PROLIFERATIVE VITREORETINOPATHY AFTER RETINAL DETACHMENT SURGERY , 2000, Retina.
[21] J. D. Cameron,et al. A new model of proliferative vitreoretinopathy. , 1998, Investigative ophthalmology & visual science.
[22] H F Edelhauser,et al. Human sclera: thickness and surface area. , 1998, American journal of ophthalmology.
[23] P. Wiedemann,et al. Proliferative vitreoretinopathy: the rabbit cell injection model for screening of antiproliferative drugs. , 1984, Journal of pharmacological methods.